Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis
Davide Povero (Povero D), Ariel E. Feldstein (Feldstein AE)
Diabetes Metab J. 2016;40(1):1-11.   Published online 2016 Feb 19     DOI: https://doi.org/10.4093/dmj.2016.40.1.1
Citations to this article as recorded by Crossref logo
TWIST2 and the PPAR signaling pathway are important in the progression of nonalcoholic steatohepatitis
Yanmei Zhang, Xiaoxiao Ge, Yongqing Li, Bingyang Zhang, Peijun Wang, Mingju Hao, Peng Gao, Yueyi Zhao, Tao Sun, Sumei Lu, Wanshan Ma
Lipids in Health and Disease.2021;[Epub]     CrossRef
Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway
In-Jin Cho, Da-Hee Oh, Jin Yoo, You-Cheol Hwang, Kyu Jeung Ahn, Ho-Yeon Chung, Soung Won Jeong, Ju-Young Moon, Sang-Ho Lee, Sung-Jig Lim, In-Kyung Jeong
Scientific Reports.2021;[Epub]     CrossRef
Angiopoietin-2 levels correlates with disease activity in children with nonalcoholic fatty liver disease
Melania Manco, Nadia Panera, Annalisa Crudele, Maria Rita Braghini, Marzia Bianchi, Donatella Comparcola, Rita De Vito, Giuseppe Maggiore, Anna Alisi
Pediatric Research.2021;[Epub]     CrossRef
Tabebuia rosea (Bertol.) DC. ethanol extract attenuates body weight gain by activation of molecular mediators associated with browning
Elsa Cecilia Pagaza-Straffon, Carla Elena Mezo-González, David Armando Chavaro-Pérez, Jorge Cornejo-Garrido, Laurence A. Marchat, Claudia G. Benítez-Cardoza, Maricruz Anaya-Reyes, Cynthia Ordaz-Pichardo
Journal of Functional Foods.2021; 86: 104740.     CrossRef
Effects of Oral Vitamin C Supplementation on Liver Health and Associated Parameters in Patients With Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial
Zhangya He, Xiaomin Li, Hexiang Yang, Pei Wu, Shanshan Wang, Dan Cao, Xiaoxiao Guo, Zhangrui Xu, Jiayi Gao, Wanyu Zhang, Xiaoqin Luo
Frontiers in Nutrition.2021;[Epub]     CrossRef
Hepatic lipid droplet homeostasis and fatty liver disease
Fabian Seebacher, Anja Zeigerer, Nora Kory, Natalie Krahmer
Seminars in Cell & Developmental Biology.2020; 108: 72.     CrossRef
Orotic acid-treated hepatocellular carcinoma cells resist steatosis by modification of fatty acid metabolism
Johanna Matilainen, Anne-Mari Mustonen, Kirsi Rilla, Reijo Käkelä, Sanna P. Sihvo, Petteri Nieminen
Lipids in Health and Disease.2020;[Epub]     CrossRef
Liver fibrogenesis: un update on established and emerging basic concepts
Erica Novo, Claudia Bocca, Beatrice Foglia, Francesca Protopapa, Marina Maggiora, Maurizio Parola, Stefania Cannito
Archives of Biochemistry and Biophysics.2020; 689: 108445.     CrossRef
Relative contribution of fat diet and physical inactivity to the development of metabolic syndrome and non-alcoholic fat liver disease in Wistar rats
Antonio Bovolini, Juliana Garcia, Maria Amparo Andrade, José Alberto Duarte
Physiology & Behavior.2020; 225: 113040.     CrossRef
Novel hepatoprotective role of Leonurine hydrochloride against experimental non-alcoholic steatohepatitis mediated via AMPK/SREBP1 signaling pathway
Li Zhang, Hui-Xia Li, Wu-Si Pan, Farhan Ullah Khan, Cheng Qian, Feng-Rong Qi-Li, Xiaojun Xu
Biomedicine & Pharmacotherapy.2019; 110: 571.     CrossRef
Association Between Nonalcoholic Fatty Liver Disease and Future Deterioration of Metabolic Health: A Cohort Study
You‐Cheol Hwang, Hong‐Yup Ahn, Cheol‐Young Park
Obesity.2019; 27(8): 1360.     CrossRef
Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer
Hongbo Wang, Zaiming Lu, Xiangxuan Zhao
Journal of Hematology & Oncology.2019;[Epub]     CrossRef
Elastography in the Diagnosis of Non-Alcoholic Fatty Liver Disease
Elena N. Shirokova, Chavdar S. Pavlov, Anna D. Karaseva, Aliya M. Alieva, Alla V. Sedova, Vladimir T. Ivashkin
Annals of the Russian academy of medical sciences.2019; 74(1): 5.     CrossRef
Curcumin Recovers Intracellular Lipid Droplet Formation Through Increasing Perilipin 5 Gene Expression in Activated Hepatic Stellate Cells In Vitro
Xiao-qun Han, San-qing Xu, Jian-guo Lin
Current Medical Science.2019; 39(5): 766.     CrossRef
Lipid mediators of liver injury in nonalcoholic fatty liver disease
Suthat Liangpunsakul, Naga Chalasani
American Journal of Physiology-Gastrointestinal and Liver Physiology.2019; 316(1): G75.     CrossRef
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Maurizio Parola, Massimo Pinzani
Molecular Aspects of Medicine.2019; 65: 37.     CrossRef
Ostreolysin induces browning of adipocytes and ameliorates hepatic steatosis
Lili Nimri, Katerina Staikin, Irena Peri, Einav Yehuda‐Shnaidman, Betty Schwartz
Journal of Gastroenterology and Hepatology.2018; 33(12): 1990.     CrossRef
miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
Chang-Hai Liu, Javier Ampuero, Antonio Gil-Gómez, Rocío Montero-Vallejo, Ángela Rojas, Rocío Muñoz-Hernández, Rocío Gallego-Durán, Manuel Romero-Gómez
Journal of Hepatology.2018; 69(6): 1335.     CrossRef
Efficient scalable production of therapeutic microvesicles derived from human mesenchymal stem cells
Jae Min Cha, Eun Kyoung Shin, Ji Hee Sung, Gyeong Joon Moon, Eun Hee Kim, Yeon Hee Cho, Hyung Dal Park, Hojae Bae, Jinseok Kim, Oh Young Bang
Scientific Reports.2018;[Epub]     CrossRef
Changes in the Structure of the Liver during Obesity (Literature Review)
V. I. Prymachenko
Ukraïnsʹkij žurnal medicini, bìologìï ta sportu.2018; 4(2): 45.     CrossRef
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
Juan Pablo Arab, Marco Arrese, Michael Trauner
Annual Review of Pathology: Mechanisms of Disease.2018; 13(1): 321.     CrossRef
Apoptosis and non-alcoholic fatty liver diseases
Tatsuo Kanda, Shunichi Matsuoka, Motomi Yamazaki, Toshikatsu Shibata, Kazushige Nirei, Hiroshi Takahashi, Tomohiro Kaneko, Mariko Fujisawa, Teruhisa Higuchi, Hitomi Nakamura, Naoki Matsumoto, Hiroaki Yamagami, Masahiro Ogawa, Hiroo Imazu, Kazumichi Kuroda
World Journal of Gastroenterology.2018; 24(25): 2661.     CrossRef
Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH
Y. Ilan, K. Shailubhai, A. Sanyal
Clinical & Experimental Immunology.2018; 193(3): 275.     CrossRef
Long-term exposure to high-sucrose diet down-regulates hepatic endoplasmic reticulum-stress adaptive pathways and potentiates de novo lipogenesis in weaned male mice
Karla Frida Torres Flister, Bruno Araújo Serra Pinto, Lucas Martins França, Caio Fernando Ferreira Coêlho, Pâmela Costa dos Santos, Caroline Castro Vale, Daniela Kajihara, Victor Debbas, Francisco Rafael Martins Laurindo, Antonio Marcus de Andrade Paes
The Journal of Nutritional Biochemistry.2018; 62: 155.     CrossRef
Blood-based novel biomarkers for nonalcoholic steatohepatitis
Yun Qiu, Sufan Wang, Ting Wan, Mingtong Ye, Rui Jiang, Lei Pei, Lili Yang
Biomarkers in Medicine.2018; 12(5): 501.     CrossRef
The effect of cannabinoid receptor 1 blockade on hepatic free fatty acid profile in mice with nonalcoholic fatty liver disease
Bojan Jorgačević, Danijela Vučević, Ivana Đuričić, Slađana Šobajić, Dušan Mladenović, Milena Vesković, Rada Ješić Vukićević, Tatjana Radosavljević
Chemistry and Physics of Lipids.2017; 204: 85.     CrossRef
Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition
Soo Hyun Kim, Gyuri Kim, Dai Hoon Han, Milim Lee, Irene Kim, Bohkyung Kim, Kook Hwan Kim, Young-Mi Song, Jeong Eun Yoo, Hye Jin Wang, Soo Han Bae, Yong-Ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Myung-Shik Lee
Autophagy.2017; 13(10): 1767.     CrossRef
Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status
Ji Hye Huh, Kwang Joon Kim, Seung Up Kim, Seung Hwan Han, Kwang-Hyub Han, Bong-Soo Cha, Choon Hee Chung, Byung-Wan Lee
Metabolism.2017; 66: 23.     CrossRef
Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease
Gyuri Kim, Kwang Joon Kim, Yumie Rhee, Sung-Kil Lim, Salvatore Petta
PLOS ONE.2017; 12(7): e0182202.     CrossRef
Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation
Jihyun Kim, Da Young Lee, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee, Susanne Kaser
PLOS ONE.2017; 12(7): e0180118.     CrossRef
Ameliorative effects of Compound K and ginsenoside Rh1 on non-alcoholic fatty liver disease in rats
Xu-Jia Chen, Wen-Jing Liu, Meng-Liang Wen, Hong Liang, Shao-Mei Wu, Yun-Zhen Zhu, Jiang-Yuan Zhao, Xiang-Qian Dong, Ming-Gang Li, Li Bian, Cheng-Gang Zou, Lan-Qing Ma
Scientific Reports.2017;[Epub]     CrossRef
Loss of miR-141/200c ameliorates hepatic steatosis and inflammation by reprogramming multiple signaling pathways in NASH
Melanie Tran, Sang-Min Lee, Dong-Ju Shin, Li Wang
JCI Insight.2017;[Epub]     CrossRef
Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis
Nada Pejnovic, Ilija Jeftic, Nemanja Jovicic, Nebojsa Arsenijevic, Miodrag L Lukic
World Journal of Gastroenterology.2016; 22(44): 9706.     CrossRef
Hepatocyte mitochondrial DNA released in microparticles and toll-like receptor 9 activation: A link between lipotoxicity and inflammation during nonalcoholic steatohepatitis
Maria Eugenia Inzaugarat, Alexander Wree, Ariel E. Feldstein
Hepatology.2016; 64(2): 669.     CrossRef
Metabolic aspects of adult patients with nonalcoholic fatty liver disease
Ludovico Abenavoli, Natasa Milic, Laura Di Renzo, Tomislav Preveden, Milica Medić-Stojanoska, Antonino De Lorenzo
World Journal of Gastroenterology.2016; 22(31): 7006.     CrossRef
Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions
Maria Grazia Clemente, Claudia Mandato, Marco Poeta, Pietro Vajro
World Journal of Gastroenterology.2016; 22(36): 8078.     CrossRef
Gut Microbiota and Metabolic Health: The Potential Beneficial Effects of a Medium Chain Triglyceride Diet in Obese Individuals
Sabri Rial, Antony Karelis, Karl-F. Bergeron, Catherine Mounier
Nutrients.2016; 8(5): 281.     CrossRef